Corvus: 2Q Earnings Snapshot

August 2, 2018

BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported a loss of $11.6 million in its second quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 40 cents.

Corvus shares have fallen 9 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.42, a decline of 20 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS

Update hourly